Skip to content

Comparative Evaluation of Post-Operative Analgesic Efficacy of two different drug volumes of same concentration of local anesthetic in patients undergoing hip fracture surgery under ultrasound guided Pericapsular Nerve Group Block around the hip joint

Comparative Evaluation of Post-Operative Analgesic Efficacy of 15 ml of 0.375 % Ropivacaine versus 25 ml of 0.375 % Ropivacaine in patients undergoing hip fracture surgery under ultrasound guided Pericapsular Nerve Group Block: A Prospective Randomised Double Blinded Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065755
Enrollment
140
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S720- Fracture of head and neck of femur Health Condition 2: S00-T88- Injury, poisoning and certain other consequences of external causes

Interventions

Intervention1: Pericapsular Nerve Group Block: Single shot PENG BLOCK administered using 15 ml of 0.375% Ropivacaine using USG and echogenic needle over 45 seconds Control Intervention1: Pericapsular

Sponsors

Aruna Bharti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient who had given written informed consent 2. Patients belonging to ASA grade I and II. 3. All genders 4. Patients in the age group of 18 yrs and above 5. Patient with hip fracture ( fracture neck of femur, intertrochanteric and subtrochanteric fractures).

Exclusion criteria

Exclusion criteria: 1. Patient refusal. 2. ASA grade III and IV 3. Emergency surgeries 4. Patients with polytrauma 5. Patient who had allergy and intolerance to local anesthetics & have active skin infection. 6. Patient with cognitive impairment, delirium, dementia and severe hearing impairment 7. Coexisting coagulopathy or anticoagulant or antiplatelet treatment that would be a contraindication to regional anesthesia. 8. Patient having diabetes, ischemic and valvular heart disease, pre-existing neurologic deficits in the limb .

Design outcomes

Primary

MeasureTime frame
1.To compare the Mean NRS (Numeric Rating Scale) to assess static and dynamic pain between two treatment groupsTimepoint: Post operative at 2,4,6,12,18,24,30,36,42 and 48 hrs

Secondary

MeasureTime frame
1. Quality of recovery at 24 & 48 hrs as measured by the QoR 15 questionnaire 2. Mean opioid consumption at 24 & 48 hrs 3. Pain score during positioning for spinal anesthesiaTimepoint: upto 48 hrs Pain during positioning at 15 mins after giving block

Countries

India

Contacts

Public ContactSonam Pandey

Sanjay Gandhi Postgraduate Institute of Medical Sciences,Lucknow

drsonam.2013@gmail.com7080635906

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026